ProKidney Corp. (PROK)
NASDAQ·Healthcare·Biotechnology
$1.84
-1.34%
Mkt Cap $561.66M
Analyst Ratings
No recent rating data.
Price Target (5 analysts)
$4.67
Range $3.00 – $6.00
Implied Upside
+154.5%
Consensus $4.67 vs current $1.84
NASDAQ·Healthcare·Biotechnology
$1.84
-1.34%
Mkt Cap $561.66M
No recent rating data.
Price Target (5 analysts)
$4.67
Range $3.00 – $6.00
+154.5%
Consensus $4.67 vs current $1.84